Northern Trust
CLDI icon

Northern Trust’s Calidi Biotherapeutics CLDI Stock Holding History

Northern Trust’s Portfolio CLDI Stock Details CLDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.24K Hold
17,758
– – ﹤0.01% 4392
2025
Q4 		$20.8K Buy
+17,758
New +$26.1K ﹤0.01% 4390
2025
Q3 		– Sell
-4,058
Closed -$11.2K – 4449
2025
Q2 		$11.2K Hold
4,058
– – ﹤0.01% 4370
2025
Q1 		$27.6K Buy
4,058
+2,397
+144% +$27.3K ﹤0.01% 4304
2024
Q4 		$22.9K Buy
+1,661
New +$31.1K ﹤0.01% 4363

Other funds holding CLDI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCI
RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust's CLDI Position: Q1 2026 in Review

Northern Trust held its Calidi Biotherapeutics (CLDI) position steady in Q1 2026 at 17,758 shares worth $4.24K. The position accounts for ﹤0.01% of the portfolio, ranked #4392.

Northern Trust first reported a position in CLDI in Q4 2024 and has held it in 5 quarters since. The position peaked at $27.6K in Q1 2025. 28 funds tracked by Wall St. Rank hold CLDI as of Q1 2026.

  • Northern Trust held 17,758 shares of Calidi Biotherapeutics worth $4.24K as of Q1 2026.
  • Northern Trust left its Calidi Biotherapeutics share count unchanged in Q1 2026.
  • Calidi Biotherapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4392 holding.
  • Northern Trust first reported a position in Calidi Biotherapeutics in Q4 2024 and has held it in 5 quarters since.
  • Northern Trust's Calidi Biotherapeutics position peaked at $27.6K in Q1 2025.
  • 28 funds tracked by Wall St. Rank held Calidi Biotherapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.